Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA

Abstract Hepatic fibrosis is a spontaneous wound-healing response triggered by chronic liver injury. Pien Tze Huang (PZH), a traditional Chinese herbal medicine, has been widely used to treat various hepatic diseases in Asia. We used a CCl4-induced mouse model to establish a PZH group of hepatic fib...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jinhang Zhu, Di Zhang, Ting Wang, Zhiliang Chen, Luan Chen, Hao Wu, Cong Huai, Jing Sun, Na Zhang, Muyun Wei, Fei Hong, Shengying Qin
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/69d4a9e5f2e24b0eabdb7c1263263085
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:69d4a9e5f2e24b0eabdb7c1263263085
record_format dspace
spelling oai:doaj.org-article:69d4a9e5f2e24b0eabdb7c12632630852021-12-02T18:51:52ZTarget identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA10.1038/s41598-021-96459-52045-2322https://doaj.org/article/69d4a9e5f2e24b0eabdb7c12632630852021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96459-5https://doaj.org/toc/2045-2322Abstract Hepatic fibrosis is a spontaneous wound-healing response triggered by chronic liver injury. Pien Tze Huang (PZH), a traditional Chinese herbal medicine, has been widely used to treat various hepatic diseases in Asia. We used a CCl4-induced mouse model to establish a PZH group of hepatic fibrosis mice treated with PZH and a control group of hepatic fibrosis mice without any treatment. We performed RNA-seq and mass spectrometry sequencing to investigate the mechanism of the PZH response in hepatic fibrosis and identified multiple differentially expressed transcripts (DETs) and proteins (DEPs) that may be drug targets of PZH. Liver functional indices, including serum albumin (ALB), alanine aminotransferase (ALT) and aspartate aminotransferase (AST), were significantly decreased in the PZH treatment group (P < 0.05) in the eighth week. Hematoxylin–eosin (HE), Masson and Sirius red staining demonstrated that PZH significantly inhibited infiltration of inflammatory cells and collagen deposition. A total of 928 transcripts and 138 proteins were differentially expressed in PZH-treated mice compared to the control group. Gene Ontology (GO) enrichment analysis suggested that PZH may alleviate liver injury and fibrosis by enhancing the immune process. Taken together, our results revealed that multiple DETs and DEPs may serve as drug targets of PZH in hepatic fibrosis patient in future clinical practice.Jinhang ZhuDi ZhangTing WangZhiliang ChenLuan ChenHao WuCong HuaiJing SunNa ZhangMuyun WeiFei HongShengying QinNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jinhang Zhu
Di Zhang
Ting Wang
Zhiliang Chen
Luan Chen
Hao Wu
Cong Huai
Jing Sun
Na Zhang
Muyun Wei
Fei Hong
Shengying Qin
Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA
description Abstract Hepatic fibrosis is a spontaneous wound-healing response triggered by chronic liver injury. Pien Tze Huang (PZH), a traditional Chinese herbal medicine, has been widely used to treat various hepatic diseases in Asia. We used a CCl4-induced mouse model to establish a PZH group of hepatic fibrosis mice treated with PZH and a control group of hepatic fibrosis mice without any treatment. We performed RNA-seq and mass spectrometry sequencing to investigate the mechanism of the PZH response in hepatic fibrosis and identified multiple differentially expressed transcripts (DETs) and proteins (DEPs) that may be drug targets of PZH. Liver functional indices, including serum albumin (ALB), alanine aminotransferase (ALT) and aspartate aminotransferase (AST), were significantly decreased in the PZH treatment group (P < 0.05) in the eighth week. Hematoxylin–eosin (HE), Masson and Sirius red staining demonstrated that PZH significantly inhibited infiltration of inflammatory cells and collagen deposition. A total of 928 transcripts and 138 proteins were differentially expressed in PZH-treated mice compared to the control group. Gene Ontology (GO) enrichment analysis suggested that PZH may alleviate liver injury and fibrosis by enhancing the immune process. Taken together, our results revealed that multiple DETs and DEPs may serve as drug targets of PZH in hepatic fibrosis patient in future clinical practice.
format article
author Jinhang Zhu
Di Zhang
Ting Wang
Zhiliang Chen
Luan Chen
Hao Wu
Cong Huai
Jing Sun
Na Zhang
Muyun Wei
Fei Hong
Shengying Qin
author_facet Jinhang Zhu
Di Zhang
Ting Wang
Zhiliang Chen
Luan Chen
Hao Wu
Cong Huai
Jing Sun
Na Zhang
Muyun Wei
Fei Hong
Shengying Qin
author_sort Jinhang Zhu
title Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA
title_short Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA
title_full Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA
title_fullStr Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA
title_full_unstemmed Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA
title_sort target identification of hepatic fibrosis using pien tze huang based on mrna and lncrna
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/69d4a9e5f2e24b0eabdb7c1263263085
work_keys_str_mv AT jinhangzhu targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna
AT dizhang targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna
AT tingwang targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna
AT zhiliangchen targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna
AT luanchen targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna
AT haowu targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna
AT conghuai targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna
AT jingsun targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna
AT nazhang targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna
AT muyunwei targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna
AT feihong targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna
AT shengyingqin targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna
_version_ 1718377389328695296